Flector and Glucophage drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Flector (diclofenac epolamine) and Glucophage (metformin hydrochloride). Common drug interactions include renal artery stenosis among females and haemorrhagic anaemia among males.

The phase IV clinical study analyzes what interactions people have when they take Flector and Glucophage. It is created by eHealthMe based on reports of 38 people who take the same drugs from the FDA, and is updated regularly.

What is Flector?

Flector has active ingredients of diclofenac epolamine. It is often used in pain. eHealthMe is studying from 5,112 Flector users. Check the latest studies of Flector.

What is Glucophage?

Glucophage has active ingredients of metformin hydrochloride. It is often used in diabetes. eHealthMe is studying from 60,851 Glucophage users. Check the latest studies of Glucophage.



On Jul, 17, 2026

38 people who take Flector and Glucophage together, and have interactions are studied.

Flector and Glucophage drug interactions.

What are the common drug interactions of Flector and Glucophage, by gender? *:

female:

  1. Renal artery stenosis (narrowing of renal artery)
  2. Renal failure (kidney dysfunction)
  3. Dehydration (dryness resulting from the removal of water)
  4. Hyperkalaemia (damage to or disease of the kidney)
  5. Metabolic acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body)
  6. Diarrhoea
  7. Hypotension (abnormally low blood pressure)
  8. Arthropathy
  9. Back injury
  10. Balance disorder

male:

  1. Haemorrhagic anaemia (anaemia due to excessive bleeding)
  2. Melaena (the passage of black, tarry stools)
  3. Mitral valve incompetence (inefficient heart valve)
  4. Hypotonia (low muscle tone)
  5. Musculoskeletal pain (pain affects the bones, muscles, ligaments, tendons, and nerves)
  6. Vascular occlusion (sudden blockage of a blood vessel, usually with a clot)
  7. Renal failure acute (rapid kidney dysfunction)
  8. Anaemia (lack of blood)
  9. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
  10. Lower gastrointestinal haemorrhage (bleeding in the large intestine, rectum, or anus is called lower gi bleeding)

What are the common drug interactions of Flector and Glucophage, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Abasia (inability to walk)
  2. Arthralgia (joint pain)
  3. Blood creatine phosphokinase increased
  4. Blood glucose increased
  5. Bone pain
  6. Myalgia (muscle pain)
  7. Pancreatitis acute (sudden inflammation of pancreas)

50-59:

  1. Abscess (pus)
  2. Carotid intima-media thickness increased (increased thickness of carotid artery muscle)
  3. Cellulitis (infection under the skin)
  4. Chronic kidney disease
  5. Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
  6. Hypotension (abnormally low blood pressure)
  7. Mitral valve incompetence (inefficient heart valve)
  8. Nephrogenic anaemia (anaemia due to kidney disease)
  9. Nephropathy (damage to or disease of a kidney)
  10. Presyncope

60+:

  1. Dehydration (dryness resulting from the removal of water)
  2. Dyspnoea (difficult or laboured respiration)
  3. Cardiovascular disorder (heart diseases)
  4. Carotid artery occlusion (artery blockage)
  5. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  6. Choking (mechanical obstruction of the flow of air from the environment into the lungs)
  7. Device occlusion
  8. Diarrhoea
  9. Dizziness
  10. Ear infection viral

What are the existing conditions these people have? *

  1. Type 2 Diabetes: 9 people, 23.68%
  2. High Blood Pressure: 8 people, 21.05%
  3. Infection: 7 people, 18.42%
  4. Bipolar Disorder (mood disorder): 7 people, 18.42%
  5. Cerebral Infarction (less blood supply to brain resulting tissue damage): 7 people, 18.42%
  6. Depression: 6 people, 15.79%
  7. Glaucoma (increased fluid pressure in the eye with vision loss): 6 people, 15.79%
  8. High Blood Cholesterol: 5 people, 13.16%
  9. Blood Pressure Abnormal: 5 people, 13.16%
  10. Cardiac Disorder: 5 people, 13.16%

* Approximation only. Some reports may have incomplete information.

Do you take Flector and Glucophage?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Flector and Glucophage:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Flector:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Glucophage:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Flector and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Glucophage and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on diclofenac epolamine and metformin hydrochloride (the active ingredients of Flector and Glucophage, respectively), and Flector and Glucophage (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: